UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in several investor conferences in September 2024. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5 and the Cantor Global Healthcare Conference 2024 on September 17, both in New York. Additionally, management will attend the 2024 Wells Fargo Healthcare Conference on September 6.
Live audio webcasts of the presentations will be available through the investors section of the Amicus Therapeutics website. This series of conference appearances underscores the company's commitment to engaging with investors and showcasing its progress in developing treatments for rare diseases.
Amicus Therapeutics (Nasdaq: FOLD), un'azienda biotecnologica globale focalizzata sulle malattie rare, ha annunciato la sua partecipazione a diverse conferenze per investitori a settembre 2024. L'azienda presenterà al 22° Annuale Global Healthcare Conference di Morgan Stanley il 5 settembre e al Cantor Global Healthcare Conference 2024 il 17 settembre, entrambi a New York. Inoltre, la direzione parteciperà al Wells Fargo Healthcare Conference 2024 il 6 settembre.
Le trasmissioni audio dal vivo delle presentazioni saranno disponibili nella sezione investitori del sito web di Amicus Therapeutics. Questa serie di apparizioni alle conferenze sottolinea l'impegno dell'azienda a interagire con gli investitori e a mostrare i suoi progressi nello sviluppo di trattamenti per le malattie rare.
Amicus Therapeutics (Nasdaq: FOLD), una empresa de biotecnología global enfocada en enfermedades raras, ha anunciado su participación en varias conferencias para inversores en septiembre de 2024. La empresa se presentará en la 22ª Conferencia Global de Salud de Morgan Stanley el 5 de septiembre y en la Conferencia Global de Salud de Cantor 2024 el 17 de septiembre, ambas en Nueva York. Además, la dirección asistirá a la Conferencia de Salud de Wells Fargo 2024 el 6 de septiembre.
Las transmisiones en vivo de las presentaciones estarán disponibles a través de la sección de inversores del sitio web de Amicus Therapeutics. Esta serie de apariciones en conferencias destaca el compromiso de la empresa de interactuar con los inversores y mostrar su progreso en el desarrollo de tratamientos para enfermedades raras.
아미쿠스 테라퓨틱스 (Nasdaq: FOLD), 희귀 질환에 집중하는 글로벌 생명공학 회사가 2024년 9월에 여러 투자자 컨퍼런스에 참석할 것이라고 발표했습니다. 회사는 9월 5일 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스와 9월 17일 캐너 글로벌 헬스케어 컨퍼런스 2024에 뉴욕에서 발표할 예정입니다. 또한 경영진은 9월 6일 2024 웰스 파고 헬스케어 컨퍼런스에도 참석할 것입니다.
프레젠테이션의 라이브 오디오 웹캐스트는 아미쿠스 테라퓨틱스 웹사이트의 투자자 섹션을 통해 제공될 것입니다. 이 일련의 컨퍼런스 참석은 투자자와의 소통 및 희귀 질환 치료 개발 과정의 진행 상황을 보여주려는 회사의 의지를 강조합니다.
Amicus Therapeutics (Nasdaq: FOLD), une entreprise de biotechnologie mondiale spécialisée dans les maladies rares, a annoncé sa participation à plusieurs conférences pour investisseurs en septembre 2024. L'entreprise présentera lors de la 22e Conférence annuelle mondiale sur la santé de Morgan Stanley le 5 septembre et lors de la Conférence mondiale sur la santé de Cantor 2024 le 17 septembre, toutes deux à New York. De plus, la direction assistera à la Conférence sur la santé de Wells Fargo 2024 le 6 septembre.
Des webcasts audio en direct des présentations seront disponibles dans la section investisseurs du site d'Amicus Therapeutics. Cette série d'apparitions à des conférences souligne l'engagement de l'entreprise à dialoguer avec les investisseurs et à démontrer ses progrès dans le développement de traitements pour les maladies rares.
Amicus Therapeutics (Nasdaq: FOLD), ein globales Biotechnologieunternehmen, das sich auf seltene Krankheiten spezialisiert hat, hat seine Teilnahme an mehreren Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird am 5. September auf der 22. jährlichen Global Healthcare Conference von Morgan Stanley und am 17. September auf der Cantor Global Healthcare Conference 2024, beide in New York, präsentieren. Außerdem wird das Management am 6. September an der 2024 Wells Fargo Healthcare Conference teilnehmen.
Live-Audio-Webcasts der Präsentationen werden im Investorenbereich der Website von Amicus Therapeutics verfügbar sein. Diese Reihe von Konferenzauftritten unterstreicht das Engagement des Unternehmens, mit Investoren in Kontakt zu treten und seinen Fortschritt bei der Entwicklung von Behandlungen für seltene Krankheiten zu präsentieren.
- None.
- None.
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.
- Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY, on Thursday, September 5, 2024, at 10:00 a.m. ET
- Cantor Global Healthcare Conference 2024 in New York, NY on Tuesday, September 17, 2024, at 1:55 p.m. ET
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
Additionally, management will attend the 2024 Wells Fargo Healthcare Conference on Friday, September 6, 2024.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When is Amicus Therapeutics (FOLD) presenting at the Morgan Stanley Global Healthcare Conference in 2024?
What investor conferences is Amicus Therapeutics (FOLD) attending in September 2024?
How can investors access the live audio webcasts of Amicus Therapeutics (FOLD) presentations?
What is the focus of Amicus Therapeutics (FOLD) as a biotechnology company?
